ThursdayJun 24, 2021 2:22 pm

QualityStocksNewsBreaks – BAND Royalty Advances Vision Through Creation of First-Ever Music-Only NFT Marketplace

BAND Royalty, an enterprising music technology company, is disrupting the music industry by introducing non-fungible tokens (“NFTs”), thus revolutionizing how fans enjoy connecting with celebrities and the way performers own their brands. In addition to delivering distinctive 3D artwork for each limited-edition series, “NFTs will also be able to be staked, in order to gain access to a library of music royalties held by BAND, meaning that the NFTs can be contractually secured to BAND’s platform for a period of time to prevent their value trading elsewhere,” reads a recent article. A limited access private pre-sale of part of BAND’s…

Continue Reading

ThursdayJun 24, 2021 2:00 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), Carester Collaborate to Build Fully Integrated Rare Earth Supply Capabilities

Energy Fuels (NYSE American: UUUU) (TSX: EFR) is collaborating with Carester SAS, a leading global expert on rare earth separation, in its ongoing commitment to developing its rare earth element (“REE”) business. As part of this effort, the companies are working to conduct a scoping study for the development of a solvent extraction REE separation circuit at Energy Fuels’ White Mesa Mill in Utah. “Energy Fuels is absolutely focused on building fully integrated rare earth supply capabilities at our White Mesa Mill in the coming years, and we are pleased to have Carester on the team to support our efforts,”…

Continue Reading

ThursdayJun 24, 2021 1:26 pm

QualityStocksNewsBreaks – Healthtech Solutions Inc. (HLTT) Positioning at Leading Edge of Cancer Treatment

Healthtech Solutions (OTC: HLTT) is positioning itself to be a leader in the burgeoning precision oncology market — projected to grow at a 9.9% CAGR from 2019 to 2027 and reach an estimated $99.7 billion — as a result of its newest acquisition: Varian Biopharmaceuticals. Varian is a precision oncology company developing novel therapeutics for the treatment of cancer — a proprietary atypical protein kinase C iota (“aPKCi”) inhibitor for the treatment of various tumor types. Its drug candidates, VAR-101 and VAR-102, leverage the company’s expertise. According to HLTT chairman David Rubin, who was quoted by a recent article, “Varian…

Continue Reading

WednesdayJun 23, 2021 3:10 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Finding New Ways to Reward and Incentivize Artists

Friendable (OTC: FDBL), a mobile technology and marketing company, recently entered an agreement with Santo Blockchain Labs and Santo Mining Corp for the development of global entertainment and musical artist-driven NFTs and the “Fanpasscrypto” marketplace. Each created NFT is a unique opportunity for a new revenue stream for artists and the two companies. A recent article reads: “Even with the upcoming NFT offering, Fan Pass is still finding ways to reward and incentivize artists, while other streaming companies are facing complaints over their revenue structures. Platforms like Apple and Spotify are taking heat because of how artist royalty distribution is…

Continue Reading

WednesdayJun 23, 2021 2:55 pm

QualityStocksNewsBreaks – Healthy Extracts Inc. (HYEX) Focused on Greater Supplement Effectiveness

Healthy Extracts (OTCQB: HYEX) develops, sells and distributes proprietary products with proven health benefits through its portfolio of wholly owned subsidiaries that currently comprises Ultimate Brain Nutrients(TM) (“UBN”) and BergametNA(TM). UBN creates formulations that improve brain health while BergametNA develops powerfully proven supplements sourced from the Citrus Bergamot Superfruit(TM) (“bergamot”) and which target cardiovascular and immune health. “Bergamot has a host of health benefits as it is a source of high concentrations of polyphenolic flavanones, measured in terms of the bergamot polyphenolic fraction (‘BPF’),” reads a recent article. Dr. Gerald Haase, MD, a clinical professor of surgery at the University…

Continue Reading

WednesdayJun 23, 2021 2:14 pm

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Setting Stage for Strengthened Demand for Blue Light Cystoscopy

Imagin Medical (CSE: IME) (OTCQB: IMEXF) is working closely with manufacturing partner Lighthouse Imaging on its proprietary i/Blue Imaging System(TM) and is on target to conduct private demonstrations at the annual American Urology Association meeting set for early September. “The updated product design will incorporate changes intended to meet critical verification requirements established through benchmark testing of competitive systems and feedback from preliminary meetings with the FDA,” reads a recent article. “The additional testing and specification development focused on the contrast agent-induced fluorescence and the ability to replicate the clinical observations in bench-level settings. The sensitivity of the system can…

Continue Reading

TuesdayJun 22, 2021 2:53 pm

QualityStocksNewsBreaks – Mobius Interactive Ltd. Levels Up to Enhance Player Experience

Mobius Interactive, an online esports and gaming operator, is leading with its esports product to take full advantage of the rapidly expanding global entertainment market. The global esports segment is on pace to nearly double its audience over the next six years to hit 646 million in 2023. As the audience grows, Mobius has leveled up to provide an engaging experience. “Mobius Interactive is committed to creating the ideal customer experience, using real-time CRM systems to ensure the entire player journey is optimized for entertainment,” reads a recent article. “Throughout its three diverse brands Mobius.bet, Club Double and Aragon Casino,…

Continue Reading

TuesdayJun 22, 2021 2:42 pm

QualityStocksNewsBreaks – Why DSG Global Inc. (DSGT) Is ‘One to Watch’

DSG Global (OTCQB: DSGT) is an emerging global technology company with interconnecting businesses in rapidly growing market segments. A recent article discusses the company’s roots in the golf industry and move into road-ready electric vehicles for delivery in the third quarter of 2021. “In 2019, the company secured exclusive North America distribution rights for Jonway Automobile Co. road-ready electric vehicles (‘EVs’). Jonway, based in Zhejiang, China, began manufacturing new vehicles s in 2003 and today produces electric powered cars, trucks, vans, SUVs, and scooters. Jonway vehicles are exported to more than 80 countries and are built to comply with U.S.…

Continue Reading

TuesdayJun 22, 2021 1:39 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Committed to Driving Novel Treatments Forward with Key Focus on Berubicin

CNS Pharmaceuticals’ (NASDAQ: CNSP) lead drug candidate, Berubicin, is a novel anthracycline, the first of which to appear capable of crossing the blood-brain barrier based on limited clinical data. The company is currently developing Berubicin in the treatment of several serious brain and central nervous system oncological indications. CNS is set to commence patient enrollment in a potentially pivotal study to evaluate the efficacy of Berubicin for adult glioblastoma multiforme (“GBM”) in the second quarter. Additionally, its sublicensee partner in Poland, WPD Pharmaceuticals, will initiate a Phase 2 multicenter clinical trial of Berubicin in adult GBM patients and is also…

Continue Reading

TuesdayJun 22, 2021 1:18 pm

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Advancing Rotigotine Development Program for Parkinson’s

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, recently announced its drug formulation and development, conducted primarily by its wholly owned German subsidiary, Vektor Pharma TF GmbH, are on schedule and continue to expand in scope. A recent article reads, “A Q1 trial announced in January 2021 and focusing on a human bioavailability pilot study of the Rotigotine transdermal patch for Parkinson’s Disease was completed in March 2021. Due to the favorable outcome of the study, the Rotigotine development program will be advanced to include a pivotal human trial.” The article, which documented XPhyto’s advancements so…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered